Nu Skin Launches Prysm iO™: A Revolutionary AI-Powered Platform for Personalized Nutritional Wellness
Stocks in this Quantisnow insightHealth Care
Historical context for NUS
Across the 7 sessions after earlier NUS headlines, the stock closed higher 4 times and lower 3 times, with a median move of 2.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | NUS | SPY |
|---|---|---|---|
| Mar 23, 2026 | Nu Skin Enterprises Appoints Chelsea Lantz as Interim Chief Financial Officer | +1.0% | +1.1% |
| Mar 10, 2026 | Nu Skin Appoints Chayce Clark as COO | -1.2% | -0.2% |
| Feb 13, 2026 | Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidanceand 1 other headline that session | -18.1% | +0.1% |
| Feb 6, 2026 | Dr. Joseph Chang Launches Update to Bestselling Book "The Aging Myth" With 15 More Years of Breakthrough Research on Cellular Wellness | +3.2% | +1.9% |
| Jan 15, 2026 | Nu Skin Enterprises to Announce Fourth Quarter and Full Year 2025 Financial Results | +2.9% | +0.3% |
| Jan 9, 2026 | Nu Skin Enterprises to Discuss Company Strategy and Opportunities at ICR Conference | +0.1% | +0.7% |
Keep researching NUS
- NUS insider tradesEvery buy and sale reported by Nu Skin Enterprises Inc. officers, directors and large holders.
- NUS earnings historyPast Nu Skin Enterprises Inc. earnings releases, newest first.
- NUS financial statementsRevenue, profit, cash flow and balance sheet from Nu Skin Enterprises Inc.'s SEC filings.
- NUS dividend historyDividends Nu Skin Enterprises Inc. has declared, with ex-dates and payment dates.
Quantisnow market dataNYSE
NUS
Nu Skin Enterprises Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- Listed since
- 1996
Get push alerts for NUS
Full NUS profile on Quantisnow Follow NUS and get a push notification the moment its next story breaks.